JHJonathan Hall

Jonathan Hall

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jonathan Hall has a total of 238 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Properties of Stereodefined Variants of Nusinersen

    by Anastasia Ashkinadze, Eva-Maria Levasseur, Lucia Yang, Mathilde Vincent, Erick E. Nakagaki-Silva, Angel E. Santorelli Villamizar, Ying-Hsiu Liu, Adrian R. Krainer, Jonathan Hall

    In the pharmaceutical industry, stereopure drugs are generally preferred over isomeric mixtures to reduce the risks of side effects and to simplify pharmacodynamics (PD) and pharmacokinetics (PK) properties. This reasoning applies equally to antisense oligonucleotides (ASOs). All current ASO drugs are modified to provide appropriate PK/PD properties. Among the modifications, phosphorothioate (PS) groups provide essential nuclease resistance and advantageous biodistribution properties. However, PS groups are chiral, with R p- and S p-centers that are challenging to incorporate stereoselectively during solid-phase synthesis, and thus current ASO drugs are diastereoisomeric mixtures. Here, we describe the synthesis of stereodefined variants of the approved drug nusinersen (Spinraza), a 2′- O -methoxyethyl-modified oligonucleotide that redirects splicing of SMN2 during treatment for spinal muscular atrophy (SMA). We found that a single 3′- S p linkage stabilizes nusinersen from degradation in mouse tissue homogenates. Although R p-nusinersen has higher target-binding affinity than S p-nusinersen, it is not more active than parent nusinersen in patient-derived cells. Finally, we show mixed results from comparing stereodefined nusinersen with parent nusinersen in a murine model of SMA. While our data do not provide definitive evidence for the superior performance of stereodefined nusinersen, we conclude that it is likely equally effective as its parent ASO, while bearing the pharmacological advantages of a single stereoisomer.

  • Open Access

    Allele-selective targeting of uromodulin by antisense oligonucleotides reduces aggregates and kidney damage in a mouse model of autosomal dominant tubulointerstitial kidney disease

    by Sebastian Sjöström, Marta Mariniello, Guglielmo Schiano, Jennifer Lake, Sara Botta, Alyssa Hill, Jonathan Hall, Olivier Devuyst

    Autosomal dominant tubulointerstitial kidney disease (ADTKD) arises from gain-of-toxic-function mutations in the UMOD gene coding for uromodulin, the most abundant protein excreted in normal urine. Mutant uromodulin accumulates in the cells lining the thick ascending limb (TAL) of the loop of Henle, leading to intracellular aggregates, cellular stress, and kidney damage. Here, we demonstrate that an antisense gapmer oligonucleotide (ASO) designed against the representative c.553C > A (p.R185S) UMOD mutation produced allele-selective silencing of the mutant messenger RNA and protein in kidney cells. Short-term administration of a murine ASO analogue in the established Umod R186S/+ mouse model of ADTKD suppressed uromodulin and lowered tubular damage, whereas a non-targeting scrambled control was inactive. After a 4-week treatment, ASO accumulation in the Umod R186S/+ kidneys reached ∼320 000 copies per TAL cell, quantified using a sensitive splint-ligation assay. The ASO treatment suppressed premature mutant uromodulin and its toxic aggregates in Umod R186S/+ kidneys, whereas it had no effects on wild-type uromodulin in Umod +/+ kidneys. Notably, the ASO improved tubular function and decreased kidney tubulointerstitial inflammation in Umod R186S/+ mice. This work offers a roadmap for antisense therapy to treat ADTKD-UMOD and substantiates the therapeutic potential of ASOs in disorders of the kidney tubule.

  • Open Access

    A qualitative and quantitative framework for the characterization of protein–RNA interactions by cross-linking mass spectrometry (XL-MS)

    by Izabela Smok, Aurélie Zbinden, Johannes Osterroth, Jianning Jiang, Frédéric H.-T. Allain, Jonathan Hall, Magdalini Polymenidou, Alexander Leitner

    Protein–RNA interactions regulate nearly all levels of gene expression. Their characterization at the molecular basis is critical for understanding the function of protein–RNA complexes, both in cell homeostasis and pathology. Yet, molecular interactions underlying the formation of these complexes remain understudied. UV cross-linking mass spectrometry (XL-MS) is one of the leading approaches for in vitro identification of protein–RNA contact sites, and for providing structural information in the form of distance constraints crucial for the refinement of structural models. Our previously published CLIR-MS method enables qualitative characterization of protein–RNA interactions at residue-specific resolution but was not designed for highly accurate quantitative interpretation. Here, we present a XL-MS workflow based on irradiation with UV light that combines data-dependent acquisition (DDA) and parallel reaction monitoring (PRM) for simultaneous detection and characterization of protein–RNA interaction sites at residue-specific resolution, followed by label-free quantification of cross-linked products. We successfully apply our combined workflow to in vitro reconstituted protein–RNA complexes formed by the proteins TDP-43 and FOX1. We report on novel RNA interaction sites located in the oligomerization interface of the N-terminal domain (NTD) of TDP-43, and characterize quantitatively the process of RNA-induced monomerization of the NTD in an RNA titration experiment. We also investigate temperature-dependent differences in the efficiency of cross-link formation in the FOX1 complex. Our framework offers a unique and novel approach to comparative quantification of protein-RNA cross-links, overcoming the limitations imposed by conventional UV XL-MS methods.

  • Open Access

    SYBR Gold staining of single stranded nucleic acids is strongly influenced by the presence of guanosines

    by Jakob Rien, Mauro Zimmermann, Jonathan Hall, Mihaela Zavolan, Nitish Mittal

    SYBR Gold is one of the most strongly fluorescent members of the SYBR family of asymmetrical cyanine dyes commonly used for staining double and single-stranded DNA and RNA. The dye fluorescence increases dramatically upon nucleic acid binding. The primary mode of binding to double-stranded DNA is through intercalation between the base-paired deoxyribonucleotides, while the precise mode of binding to single-stranded DNA and to RNA is less well understood. Here we show that the fluorescence activity of SYBR Gold is strongly influenced by the presence of guanines in single-stranded nucleic acids. We expect this insight to aid in the evaluation of SYBR Gold-based measurements of nucleic acid abundance and spark further studies into the binding behaviour of the SYBR family dyes.


  • Open Access

    Properties of Stereopure Phosphorothioate Groups in RNA-PROTACs

    by Mathilde Vincent, Jonathan Hall

    Proteolysis-targeting chimeras (PROTACs) are an emerging therapeutic modality that enable the degradation of target proteins via the endogenous ubiquitin–proteasome pathway. We are applying this concept to the degradation of RNA-binding proteins (RBPs), which often lack drug-like binding pockets for small molecules. When targeting RBPs with RNA-PROTACs, the targeting ligand consists of short, chemically modified oligoribonucleotides that are iso-sequential with endogenous RNA consensus sequences. Specifically, we are investigating the phosphorothioate (PS) backbone, in which a sulfur atom replaces a non-bridging oxygen in the RNA phosphodiester linkage. PS modifications enhance stability against nucleases, but introduce chirality at the phosphorus atom, when introduced using conventional synthesis reagents, generating diastereoisomers whose stereochemistry can significantly enhance RNA–protein interactions.


  • Open Access

    A highly sensitive protein-RNA cross-linking mass spectrometry workflow with enhanced structural modeling potential

    by Chris P Sarnowski, Anna Knörlein, Tebbe de Vries, Michael Götze, Irene Beusch, Ruedi Aebersold, Frédéric H-T Allain, Jonathan Hall, Alexander Leitner

    Protein–RNA interactions underpin many critical biological processes, demanding the development of technologies to precisely characterize their nature and functions. Many such technologies depend upon cross-linking under mild irradiation conditions to stabilize contacts between amino acids and nucleobases; for example, the cross-linking of stable isotope labelled RNA coupled to mass spectrometry (CLIR-MS) method. A deeper understanding of the CLIR-MS workflow is required to maximize its impact for structural biology, particularly addressing the low abundance of cross-linking products and the information content of spatial/geometric restraints reflected by a cross-link. Here, we present a vastly improved CLIR-MS pipeline that features enhanced sample preparation, data acquisition and interpretation. These advances significantly increase the number of detected cross-link products per sample. We demonstrate that the procedure is robust against variation of key experimental parameters, including irradiation energy and temperature. Using this improved protocol on four protein-RNA complexes representing canonical and non-canonical RNA-binding domains, we propose for the first time the distances encoded by protein-RNA cross-links, enabling their use as structural restraints. We also compared the cross-linking of canonical RNA with 4-thiouracil-labeled counterparts, showing slight, but noticeable differences. The improved understanding of protein-RNA cross-links refines their structural interpretation and facilitates the adoption of the method in integrative/hybrid structural biology.


  • Open Access

    Correction: Schlösser et al. Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells. Non-Coding RNA 2025, 11, 8

    by Verena Schlösser, Helen Louise Lightfoot, Christine Leemann, Seyedeh Elnaz Banijamali, Aathma Merin Bejoy, Shashank Tiwari, Jeffrey L. Schloßhauer, Valentina Vongrad, Andreas Brunschweiger, Jonathan Hall, et al.

    Seyedeh Elnaz Banijamali was not included as an author in the original publication


  • Open Access

    miRNA‐29 regulates epidermal and mesenchymal functions in skin repair

    by Lalitha Thiagarajan, Rosa Sanchez‐Alvarez, Chiho Kambara, Poojitha Rajasekar, Yuluang Wang, François Halloy, Jonathan Hall, Hans‐Jürgen Stark, Iris Martin, Petra Boukamp, et al.

    MicroRNAs (miRNAs) control organogenesis in mammals by inhibiting translation of mRNA. Skin is an excellent model to study the role of miRNAs in epidermis and the mesenchyme. Previous research demonstrated miRNA‐29 family functions in skin; however, the mRNA targets and the downstream mechanisms of miRNA‐29‐mediated regulation are missing. We used the miRNA crosslinking and immunoprecipitation method to find direct targets of miRNA‐29 in keratinocytes and fibroblasts from human skin. miRNA‐29 inhibition using modified antisense oligonucleotides in 2D and 3D cultures of keratinocytes and fibroblasts enhanced cell‐to‐matrix adhesion through autocrine and paracrine mechanisms of miRNA‐29‐dependent tissue growth. We reveal a full transcriptome of human keratinocytes with enhanced adhesion to the matrix, which supports regeneration of the epidermis and is regulated by miRNA‐29. Impact statement: The functions of small, therapeutically targetable microRNA molecules identified in our study can provide a new approach to improve wound healing by restoring and enhancing the inner molecular mechanisms of a cell and its surrounding matrix. We also provide a plethora of new mRNA targets for follow‐up studies of cell adhesion and extracellular matrix formation in humans.


  • Open Access

    Oligonucleotide-based PROTACs to Degrade RNA- and DNA-Binding Proteins

    by Céline N. Weller, Jonathan Hall

    Proteolysis targeting chimeras (PROTACs) are heterobifunctional molecules that sequester the endogenous protein degradation machinery of cells to induce degradation of targeted proteins. By bringing a target protein and a ubiquitin E3 ligase into close proximity, ubiquitin monomers can be transferred onto surface lysines of the protein, which is subsequently degraded by the proteasome. The functions of RNA- and DNA-binding proteins have been especially hard to modulate with small molecules. However, oligonucleotides that bind RNA- or DNA-binding proteins can be turned into oligonucleotide-based PROTACs to direct ubiquitination and degradation of these proteins. Here we summarize the current state of the field of oligonucleotide-based PROTACs that target RNA- or DNA-binding proteins.


  • Open Access

    Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells

    by Verena Schlösser, Helen Louise Lightfoot, Christine Leemann, Seyedeh Elnaz Banijamali, Aathma Merin Bejoy, Shashank Tiwari, Jeffrey L. Schloßhauer, Valentina Vongrad, Andreas Brunschweiger, Jonathan Hall, et al.

    Background: Despite tremendous advances in antiretroviral therapy (ART) against HIV-1 infections, no cure or vaccination is available. Therefore, discovering novel therapeutic strategies remains an urgent need. In that sense, miRNAs and miRNA therapeutics have moved intensively into the focus of recent HIV-1-related investigations. A strong reciprocal interdependence has been demonstrated between HIV-1 infection and changes of the intrinsic cellular miRNA milieu. This interrelationship may direct potential alterations of the host cells’ environment beneficial for the virus or its suppression of replication. Whether this tightly balanced and controlled battle can be exploited therapeutically remains to be further addressed. In this context, the fluoroquinolone antibiotic Enoxacin has been demonstrated as a potent modulator of miRNA processing. Here, we test the hypothesis that this applies also to selected HIV-1-related miRNAs. Methods: We studied the effect of Enoxacin on HIV-1 replication coupled with miRNA qRT-PCR analysis of HIV-1-related miRNAs in CEM-SS and MT-4 T-cells. The effects of miRNA mimic transfections combined with Enoxacin treatment on HIV-1 replication were assessed. Finally, we employed an in vitro DICER1 cleavage assay to study the effects of Enoxacin on a pro-HIV-1 miRNA hsa-miR-132 processing. Results: We established that Enoxacin, but not the structurally similar compound nalidixic acid, exhibits strong anti-HIV-1 effects in the T-cell line CEM-SS, but not MT-4. We provide experimental data that this effect of Enoxacin is partly attributed to the specific downregulation of mature hsa-miR-132-3p, but not other tested pro- or anti-HIV-1 miRNAs, which is likely due to affecting DICER1 processing. Conclusions: Our findings show an anti-retroviral activity of Enoxacin at least in part by downregulation of hsa-miR-132-3p, which may be relevant for future antiviral therapeutic applications by modulation of the RNA interference pathway.